Recent Updates
Recently added Catalysts
CGON Positive Sentiment

CG Oncology to Present at Upcoming Investor Conferences in June

Key Takeaway: CG Oncology, Inc. has announced that its CEO, Arthur Kuan, will present at two significant investor conferences in June 2026. The events include the Jefferies Global Healthcare Conference in New York and the Goldman Sachs 47th Annual Global Healthcare Conference in Miami. These presentations aim to enhance investor engagement and showcase the company's advancements in bladder cancer therapies.
Price reaction · baseline $60.8 (2026-05-27 close) · hit after-hours · 1 other CGON headline(s) in the window, move may be shared
day 0 close
-0.1%

Conference Participation Details

Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • CG Oncology is actively engaging with investors through presentations.
  • The company is focused on innovative therapies for bladder cancer.
  • The CEO's participation in major healthcare conferences highlights company visibility.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+139%
120-day peak, hindsight
Typical move
6.3%
average across 5 past catalysts
Cash runway
~66 mo
Minimal dilution risk
Lead asset
CG0070
Phase 2 · Non Muscle Invasive Bladder Cancer

Full Press Release Details

DALLAS, May 28, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman, President & Chief Executive Officer, will participate in fireside chat presentations at the Jefferies Global Healthcare Conference and the Goldman Sachs 47th Annual Global Healthcare Conference this month. The details of the upcoming events are as follows:

Jefferies Global Healthcare ConferenceDate: Wednesday, June 3, 2026Presentation Time: 10:30-11:00 AM ETLocation: New York, New York

Goldman Sachs 47th Annual Global Healthcare ConferenceDate: Tuesday, June 9, 2026Presentation Time: 2:40-3:15 PM ETLocation: Miami, Florida

Interested parties may access the live audio webcast for the conferences from theInvestor Relations sectionof the company's website atwww.cgoncology.com. The webcast replays will be available shortly after the conclusion of the live presentations and archived for approximately 90 days.
About CG OncologyCG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology sees a world where urologic cancer patients may benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. To learn more, please visit: www.cgoncology.com.

Frequently Asked Questions

When will CG Oncology present at the Jefferies Conference?

CG Oncology will present at the Jefferies Global Healthcare Conference on June 3, 2026.

Who is the CEO of CG Oncology?

Arthur Kuan is the Chairman, President, and CEO of CG Oncology.

Where will the Goldman Sachs conference take place?

The Goldman Sachs 47th Annual Global Healthcare Conference will be held in Miami, Florida.

How can I access the conference webcasts?

Live audio webcasts can be accessed from the Investor Relations section of CG Oncology's website.

Last updated: May 28, 2026